Pfizer Long Term Debt 2010-2024 | PFE

Pfizer long term debt for the quarter ending September 30, 2024 was $58.002B, a 4.99% decline year-over-year.

  • Pfizer long term debt for 2023 was $61.538B, a 87.14% increase from 2022.
  • Pfizer long term debt for 2022 was $32.884B, a 9.15% decline from 2021.
  • Pfizer long term debt for 2021 was $36.195B, a 2.53% decline from 2020.

Pfizer Long Term Debt 2010-2024 | PFE

  • Pfizer long term debt for 2023 was $61.538B, a 87.14% increase from 2022.
  • Pfizer long term debt for 2022 was $32.884B, a 9.15% decline from 2021.
  • Pfizer long term debt for 2021 was $36.195B, a 2.53% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B